Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Pioglitazone in Combination With Glimepiride in Comparison to Glimepiride Monotherapy on Metabolic Control in Patients With Type 2 Diabetes Mellitus

NCT00770952 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00770952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00770952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Pioglitazone in Combination With Glimepiride in Comparison to Glimepiride Monotherapy on Metabolic Control in Patients With Type 2 Diabetes Mellitus
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2006
Completion date
December 31, 2008
Enrollment
91 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus